Efficacy of risankizumab by baseline clinical, biochemical, and endoscopic disease severity in moderately to severely active crohn's diseaseRemo Panaccione,Geert D'Haens,John Paul Seenan,Flavio Caprioli,Corey A. Siegel,Masanao Nakamura,Shu Chen Wei,Kristina Kligys,Yafei Zhang,Javier A. Zambrano,Alexandra P. Song,Marc FerranteGASTROENTEROLOGY(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要